Cutler Group LP Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	BUY	$34.92 - $46.66 $73,332 - $97,986	2,100 New	2,100 $21,000
Q2 2022 Aug 04, 2022	SELL	$45.8 - $85.4 $87,020 - $162,260	-1,900 Reduced 76.0%	600 $4,000
Q4 2020 Jan 21, 2021	BUY	$84.4 - $177.39 $211,000 - $443,474	2,500 New	2,500 $46,000
Q1 2019 May 10, 2019	SELL	$39.87 - $69.36 $79,740 - $138,720	-2,000 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$38.89 - $77.3 $116,670 - $231,900	-3,000 Reduced 60.0%	2,000 $7,000
Q3 2018 Nov 07, 2018	SELL	$71.81 - $90.15 $359,050 - $450,750	-5,000 Reduced 50.0%	5,000 $32,000
Q2 2018 Aug 10, 2018	BUY	$48.54 - $85.31 $485,400 - $853,100	10,000 New	10,000 $12,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.